The present results differ from previously reported data on other malignant cancers, which showed a decrease in LATS2 mRNA levels in tumor tissue [26,28], implying that LATS2 may have different roles in different types of cells and/or cancers. This evidence concerns the gene LATS2 and neoplasm.